| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
immunity related GTPase M | 0.617 | 0.538 |
|
disease | 0.700 | None | 0.939 | 3 | 3 | 2007 | 2020 | |||||||||
|
long intergenic non-protein coding RNA 1475 | 0.780 | 0.077 |
|
disease | 0.100 | None | 1.000 | 2 | 3 | 2007 | 2007 | |||||||||
|
long intergenic non-protein coding RNA 824 | 0.695 | 0.346 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2017 | |||||||||
|
small Cajal body-specific RNA 5 | 1.000 | 0.038 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2010 | 2013 | |||||||||
|
psoriasis susceptibility 1 candidate 3 | 0.769 | 0.269 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||||||
|
RTEL1-TNFRSF6B readthrough (NMD candidate) | 0.682 | 0.385 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2008 | 2017 | |||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
long intergenic non-protein coding RNA 2471 | 0.861 | 0.154 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2008 | 2008 | |||||||||
|
long intergenic non-protein coding RNA 2341 | 0.751 | 0.231 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2017 | |||||||||
|
LRRK2 divergent transcript | 0.861 | 0.154 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2008 | 2008 | |||||||||
|
non-coding RNA in the aldehyde dehydrogenase 1A pathway | 0.792 | 0.192 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2008 | 2016 | |||||||||
|
MIR3936 host gene | 0.861 | 0.269 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2007 | 2007 | |||||||||
|
nitric oxide synthase 2 pseudogene 1 | 1.000 | 0.038 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2007 | 2007 | |||||||||
|
THADA armadillo repeat containing | 0.686 | 0.500 | 4.6E-41 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2017 | ||||||||
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
disease | 0.400 | None | 1.000 | 1 | 1 | 2010 | 2016 | ||||||||
|
mucin 19, oligomeric | 0.736 | 0.615 | 6.2E-32 |
|
disease | 0.130 | None | 1.000 | 1 | 1 | 2010 | 2018 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 1.000 | moderate | 0.937 | 12 | 20 | 1998 | 2019 | ||||||||
|
leucine rich repeat kinase 2 | 0.510 | 0.808 | 2.6E-30 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 2008 | 2019 | ||||||||
|
endoplasmic reticulum aminopeptidase 2 | 0.615 | 0.577 | 1.0E-28 |
|
disease | 0.420 | None | 1.000 | 1 | 1 | 2010 | 2017 | ||||||||
|
testis expressed 9 | 0.839 | 0.154 | 6.4E-22 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2007 | 2007 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.200 | None | 0.800 | 2 | 1 | 2005 | 2018 | ||||||||
|
macrophage stimulating 1 | 0.465 | 0.885 | 4.8E-19 |
|
disease | 0.500 | None | 1.000 | 2 | 1 | 2008 | 2018 | ||||||||
|
glucokinase regulator | 0.604 | 0.615 | 8.5E-19 |
|
disease | 0.110 | None | 1.000 | 2 | 2 | 2008 | 2017 | ||||||||
|
period circadian regulator 3 | 0.559 | 0.731 | 1.4E-17 |
|
disease | 0.130 | None | 1.000 | 1 | 1 | 2010 | 2016 | ||||||||
|
autophagy related 16 like 2 | 0.769 | 0.462 | 4.7E-16 |
|
disease | 0.140 | None | 1.000 | 1 | 1 | 2014 | 2019 |